Analyst Activity – Cantor Fitzgerald Reiterates Buy on Strongbridge Biopharma (NASDAQ:SBBP)

Analyst Ratings For Strongbridge Biopharma (NASDAQ:SBBP)

Story continues below

Today, Cantor Fitzgerald reiterated its Buy rating on Strongbridge Biopharma (NASDAQ:SBBP) with a price target of $14.00.

Some recent analyst ratings include

  • 3/12/2018-Cantor Fitzgerald Reiterated Rating of Buy.
  • 1/18/2018-HC Wainwright Reiterated Rating of Buy.
  • 8/10/2017-Oppenheimer initiated coverage with a Outperform rating.
  • 12/28/2016-JMP Securities Reiterated Rating of Outperform.

    Recent Trading Activity for Strongbridge Biopharma (NASDAQ:SBBP)
    Shares of Strongbridge Biopharma closed the previous trading session at 7.42 down -0.33 4.29% with 7.25 shares trading hands.

    An ad to help with our costs